Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Ribociclib
Related studies linked through entity extraction aliases.
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
(VELA) Study of BLU-222 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Roll-over Study to Allow Continued Access to Ribociclib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors
- Status
- COMPLETED
- Phase
- N/A
Managed Access Programs for LEE011, Ribociclib
- Status
- AVAILABLE
- Phase
- N/A
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
- Status
- RECRUITING
- Phase
- PHASE3
Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.
- Status
- UNKNOWN
- Phase
- N/A
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
- Status
- TERMINATED
- Phase
- NA
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts
- Status
- TERMINATED
- Phase
- PHASE4
Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics
- Status
- RECRUITING
- Phase
- PHASE1
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study
- Status
- TERMINATED
- Phase
- PHASE2
Ribociclib and Spartalizumab in R/M HNSCC
- Status
- UNKNOWN
- Phase
- PHASE1
A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.
- Status
- RECRUITING
- Phase
- PHASE2